{"abstract": "Christopher A. Viehbacher, chief executive of Sanofi-Aventis, cites \u201cgood progress\u201d in talks, but says that due diligence is taking time.", "web_url": "https://dealbook.nytimes.com/2011/02/09/sanofi-says-it-may-extend-genzyme-offer/", "snippet": "Christopher A. Viehbacher, chief executive of Sanofi-Aventis, cites \u201cgood progress\u201d in talks, but says that due diligence is taking time.", "lead_paragraph": "Sanofi-Aventis may seek another extension of its tender offer to acquire Genzyme, Christopher A. Viehbacher, chief executive of Sanofi-Aventis, a French drug maker, said in an interview on Wednesday.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Sanofi Says It May Extend Genzyme Offer", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Genzyme Corp", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Sanofi-Aventis S.A", "rank": 2, "major": "N"}], "pub_date": "2011-02-09T18:20:23+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Duff Wilson", "person": [{"firstname": "Duff", "middlename": null, "lastname": "Wilson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/f45e4422-9865-56a8-8870-dbdc9f8cefc6", "word_count": 328, "uri": "nyt://article/f45e4422-9865-56a8-8870-dbdc9f8cefc6"}